Kwangdong Pharmaceutical Wins Minister of Trade, Industry and Energy Award at the 32nd Corporate Innovation Awards
Building a Company-wide Digital Transformation Foundation
Recognized for Excellence in ESG Management Performance
Kwangdong Pharmaceutical announced on December 10 that it received the Minister of Trade, Industry and Energy Award at the 32nd Corporate Innovation Awards, co-hosted by the Korea Chamber of Commerce and Industry and the Ministry of Trade, Industry and Energy.
Kwangdong Pharmaceutical was honored with this award in recognition of its company-wide digital innovation efforts, transparent disclosure of ESG information, and genuine achievements in sustainable management.
At the 32nd Corporate Innovation Awards Ceremony, Kwangdong Pharmaceutical received the Minister of Trade, Industry and Energy Award. Kwangdong Pharmaceutical
View original imageThis year, the company established an AI Center and applied big data and artificial intelligence (AI) technologies to research and development (R&D) innovation and production planning optimization, thereby building a foundation for digital transformation (DX). Through these initiatives, Kwangdong Pharmaceutical achieved improved work efficiency across the organization and further strengthened its digital capabilities.
Additionally, the company has made ESG management a core mid- to long-term priority, established a dedicated organization, and set up a management system focused on sustainability. Notably, Kwangdong Pharmaceutical voluntarily participated in the Environmental Information Disclosure System, even though it was not mandatory, and transparently released key environmental data, thereby increasing management credibility. Furthermore, by introducing solar power generation projects and replacing high-efficiency heat pumps, the company has achieved tangible reductions in greenhouse gas emissions, energy consumption, and waste generation, delivering results in eco-friendly management.
Kwangdong Pharmaceutical is also taking the lead in promoting public health and creating social value. By signing contracts with global pharmaceutical companies, it has introduced orphan drugs and provided support for medication costs, thereby improving public access to pharmaceuticals. The company has also been recognized as a "Certified Social Contribution Company" and continues to engage in various social contribution activities, such as operating an employee matching grant program.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Kwangdong Pharmaceutical representative stated, "This award is the result of the efforts of all executives and employees to pursue innovation and fulfill our social responsibilities in a rapidly changing business environment," adding, "Kwangdong Pharmaceutical will continue to strengthen digital transformation and ESG management to create sustainable corporate value."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.